News

Successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay

Interview with the Dr. Risch AIOS-Team about the successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay

Read more

Succesful implementation of Quantum Blue­® Adalimumab and Anti-Adalimumab

Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.

Read more

Successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay

Interview with Christophe Zehnder about the successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay

Read more

BÜHLMANN Posters at UEGW 2023

Discover insightful posters from BÜHLMANN focusing on calprotectin assay standardization, presented at the United European Gastroenterology Week 2023!

Read more